Medical Developments International Ltd MVP
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- A$0.37
- Day Range
- A$0.37–0.38
- 52-Week Range
- A$0.37–0.72
- Bid/Ask
- A$0.37 / A$0.38
- Shares Outstanding
- 112.66M
- Market Cap
- A$41.12M
- Volume/Avg
- 180,243 / 174,824
Key Statistics
- Price/Earnings (Normalized)
- 31.81
- Price/Sales
- 1.01
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Medical Developments International Ltd manufactures Penthrox (the Green Whistle), an inhaled analgesic for acute trauma and procedural pain, at manufacturing facilities at Scoresby and Springvale in Victoria, Australia. Its operating segments are Pain Management and Respiratory, with Pain Management generating maximum revenue. The Respiratory segment supplies space chambers, peak flow meters, portable nebulisers and silicone face masks to aid sufferers of asthma and chronic obstructive pulmonary disease (COPD). Geographically, Penthrox is sold into domestic and international markets through distribution partnerships and direct in-market capability, while the Respiratory segment supplies into Australia, the USA, Europe and Asia through partnership with distributors.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 68
- Website
- https://www.medicaldev.com
Valuation
|
Metric
|
MVP
|
|---|---|
Price/Earnings (Normalized) | 31.81 |
Price/Book Value | 0.74 |
Price/Sales | 1.01 |
Price/Cash Flow | 7.50 |
Price/Earnings
MVP
Financial Strength
|
Metric
|
MVP
|
|---|---|
Quick Ratio | 4.55 |
Current Ratio | 5.77 |
Interest Coverage | — |
Quick Ratio
MVP
Profitability
|
Metric
|
MVP
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
MVP
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|#Q@gTPc& | LOCK|$^VpK | $74B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|r#hp#lj | LOCK|@FWNh | $48B | |||
| Haleon PLC ADR
HLN
| LOCK|nfQTly | LOCK|ZvM | $38B | |||
| Zoetis Inc Class A
ZTS
| LOCK|><>!Q$S | LOCK|DN! | $33B | |||
| Viatris Inc
VTRS
| LOCK|wqB!^> | LOCK|@& | $22B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|^&#>%l | LOCK|zDt | $12B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|%pV | LOCK|b& | $12B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|^#!$t% | LOCK|%QP | $6B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|cn!B#^ | LOCK|!c!L< | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|%$<&j^F | LOCK|!^ | $2B |
United States